46 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Neurotrope, Inc. NTRP shares jumped 114.5% to $3.11 on above 50 times average volume following a corporate update from the company. Following the completion of data analysis for a confirmatory Phase 2 study dubbed "203 study" that evaluated its experimental Alzheimer's disease candidate Bryostatin-1, Neurotrope said the data showed improvement in cognitive function of pre-specified Moderate Stratum patients at week 13, which is the primary endpoint. Neurotrope also announced it has been awarded a $2.7 million funding from the National Institute of Health to support an additional Phase 3 study focused on the Moderate Stratum for which it reported an improvement. The company said it plans to meet with the FDA to present the totality of data from the NTRP101-202 and NTRP101-203 studies.
• Genprex, Inc. GNPX shares climbed 54.8% to $1.78 after climbing 219.44% on Tuesday.
• One Stop Systems, Inc. OSS shares climbed 41.5% to $2.90 after the company issued Q4 and FY19 sales guidance above analyst estimates.
• Trillium Therapeutics Inc. TRIL gained 19% to $3.32 on heightened volume.
• Express, Inc. EXPR rose 17.7% to $4.8856 after the company narrowed its Q4 earnings forecast and announced plans to close 100 stores by 2022.
• CEL-SCI Corporation CVM shares gained 14.5% to $14.12.
• Aethlon Medical, Inc. AEMD rose 14.2% to $2.6350 after gaining 12.14% on Tuesday.
• Baudax Bio, Inc. BXRX gained 13.6% to $8.00. Baudax Bio announced Feb. 20 PDUFA date for intravenous meloxica.
• Tarena International, Inc. TEDU shares rose 13.2% to $3.78.
• LexinFintech Holdings Ltd. LX shares jumped 12.4% to $16.43.
• Franklin Financial Network, Inc. FSB gained 10.5% to $37.73. FB Financial Corporation announced a merger with Franklin Financial Network.
• Tetraphase Pharmaceuticals, Inc. TTPH shares rose 10.5% to $3.27.
• XPEL, Inc. XPEL gained 10.4% to $16.99.
• Qutoutiao Inc. QTT shares jumped 10.2% to $4.7053. Qutoutiao announced resignation of Director and CFO. Qutoutiao also filed prospectus supplement relating to resale from time to time of 5.9 million ADSs by selling shareholder.
• Exact Sciences Corporation EXAS shares jumped 10% to $94.50. UBS analysts noted that companies with liquid biopsy tests for colon cancer screening will present at this week's 2020 Gastrointestinal Cancers Symposium, but they still 'lag well behind' Exact's Cologuard.
• Soligenix, Inc. SNGX shares surged 10% to $2.63.
• Akcea Therapeutics, Inc. AKCA gained 9.5% to $18.99. Akcea and Ionis reported topline Phase 2 results of AKCEA-APOCIII-L Rx.
• Navient Corp NAVI rose 9.2% to $15.13 after the company reported better-than-expected Q4 EPS results.
• Virgin Galactic Holdings, Inc. SPCE rose 9.1% to $18.88 after climbing 10.61% on Tuesday.
• Soleno Therapeutics, Inc. SLNO shares surged 9% to $3.6484.
• NeoPhotonics Corporation NPTN rose 8.5% to $9.31.
• Superior Industries International, Inc. SUP gained 7.5% to $3.59.
• Moderna Inc MRNA gained 7.5% to $22.50 after the company announced it is working with US health agencies to develop a vaccine for the Wuhan Coronavirus.
• Adaptimmune Therapeutics PLC - ADR ADAP rose 6.3% to $4.40 despite the company reporting a public offering of 21 million ADS at $4 per ADS.
• Ally Financial Inc ALLY climbed 5.8% to $32.00 after the company reported better-than-expected Q4 financial results.
• BioNTech SE BNTX shares rose 5% to $38.37 after climbing 10.13% on Tuesday.
• Tesla Inc TSLA gained 4.5% to $571.94 after Wedbush analysts raised their price target on the stock from $370 to $550, citing strong expected deliveries amid China demand.
• ACM Research, Inc. ACMR rose 4.3% to $44.51. Morgan Stanley initiated coverage on ACM Research with an Overweight rating and a $45 price target.
• International Business Machines Corporation IBM shares rose 3.6% to $144.21 after the company reported better-than-expected fourth-quarter results. The company also issued fiscal year 2020 EPS guidance above analyst estimates.

Check out these big penny stock gainers and losers

Losers

• NanoViricides, Inc. NNVC shares dipped 51.1% to $4.16 after rising 152.98% on Tuesday. NanoViricides priced 2.5 million share underwritten public offering of common stock at $3.00 per share.
• FuelCell Energy Inc FCEL shares fell 24.7% to $2.17 after the company reported worse-than-expected Q4 results.
• Novavax, Inc. NVAX shares fell 19.7% to $7.89 after the company filed for a $100 million mixed shelf offering.
• Alpha Pro Tech, Ltd. APT fell 13.2% to $4.21 after surging 38.57% on Tuesday.
• ImmuCell Corporation ICCC dipped 13% to $5.15.
• Lilis Energy, Inc. LLEX fell 13% to $0.2350 after Stifel Nicolaus downgraded the stock from Buy to Hold.
• Costamare Inc. CMRE dropped 10.1% to $9.30.
• NeuroMetrix, Inc. NURO dropped 10.1% to $3.94.
• Hutchison China MediTech Limited HCM fell 10% to $26.56.
• Lakeland Industries, Inc. LAKE dropped 9.2% to $12.51.
• Canaan Inc. CAN shares declined 8.6% to $5.21.
• Blueprint Medicines Corp BPMC fell 8.2% to $73.19 after the company reported a proposed public offering of $325 million of shares of common stock.
• CounterPath Corporation CPAH shares declined 8% to $2.30.
• Mereo BioPharma Group plc MREO shares tumbled 7.8% to $2.00.
• Ocean Power Technologies Inc OPTT fell 5.8% to $0.8301 after the company filed for a 5.4 million share common stock offering by selling shareholder.
• Plug Power Inc. PLUG shares fell 5.6% to $4.08.
• Zions Bancorporation, National Association ZION fell 5% to $47.48 after the company reported worse-than-expected Q4 results. Bank of America analysts today downgraded the company's stock from Buy to Neutral.